Hostname: page-component-7b7567c8c-mnklg Total loading time: 0 Render date: 2026-11-12T05:22:14.419Z Has data issue: false hasContentIssue false

Differences in the incidence of nosocomial-onset COVID-19 among hospitalized patients with exposure to SARS-CoV-2

Published online by Cambridge University Press:  14 March 2024

Masataka Nakagawa
Affiliation:
Division of Infection Control, Department of Quality and Safety in Healthcare, Fujita Health University Hospital, Aichi, Japan
Yumiko Fujishiro
Affiliation:
Division of Infection Control, Department of Quality and Safety in Healthcare, Fujita Health University Hospital, Aichi, Japan
Yohei Doi
Affiliation:
Department of Infectious Diseases, Fujita Health University School of Medicine, Aichi, JapanDivision of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Junichi Yamakami
Affiliation:
Department of Quality and Safety in Healthcare, Fujita Health University Hospital, Aichi, Japan
Hitoshi Honda*
Affiliation:
Division of Infection Control, Department of Quality and Safety in Healthcare, Fujita Health University Hospital, Aichi, JapanDepartment of Infectious Diseases, Fujita Health University School of Medicine, Aichi, Japan
*
Corresponding author: Hitoshi Honda; Email: hitoshihonda@fujita-hu.ac.jp
Rights & Permissions [Opens in a new window]

Abstract

We evaluated the secondary COVID-19 incidence among uninfected hospitalized patients after nosocomial COVID-19 exposure. An exposure source of SARS-CoV-2 was hospitalized patients or healthcare personnel (HCP) newly diagnosed as having COVID-19. Patients exposed to a COVID-19-infected patient in a shared room more frequently developed COVID-19 than those exposed to an infected HCP.

Information

Type
Concise Communication
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America
Figure 0

Table 1.Proportion of nosocomial-onset COVID-19 stratified by their patient location and exposure source